tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mike Matson, 589 are a BUY (87.13%), 83 are a HOLD (12.28%), 4 are a SELL (0.59%).
Analyst Mike Matson, currently employed at NEEDHAM, carries an average stock price target met ratio of 65.67% that have a potential upside of 26.54% achieved within 278 days.
Mike Matson’s has documented 1,147 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 30-Sep-2025.
Analyst best performing recommendations are on PSNL (PERSONALIS).
The best stock recommendation documented was for PSNL (PERSONALIS) at 6/21/2024. The price target of $3.5 was fulfilled within 28 days with a profit of $2.28 (186.89%) receiving and performance score of 66.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$45
$10.19 (29.27%)
$44
2 months 9 days ago
(29-Jul-2025)
13/33 (39.39%)
$9.87 (28.10%)
184
Buy
$58
$23.19 (66.62%)
$40
5 months 9 days ago
(29-Apr-2025)
5/13 (38.46%)
$28.09 (93.92%)
302
Buy
$52
$17.19 (49.38%)
$66
6 months 11 days ago
(27-Mar-2025)
2/17 (11.76%)
$20.17 (63.37%)
36
Buy
$45
$10.19 (29.27%)
$36
7 months 26 days ago
(12-Feb-2025)
10/11 (90.91%)
$5.41 (13.67%)
113
Buy
$48
$13.19 (37.89%)
$26
7 months 26 days ago
(12-Feb-2025)
10/12 (83.33%)
$8.41 (21.24%)
105
Which stock is Mike Matson is most bullish on?
Which stock is Mike Matson is most reserved on?
What Year was the first public recommendation made by Mike Matson?
